Charles River - JP Morgan Conference Presentation

Capitalizing on the rapid expansion of biologics and C&GT pipelines Manufacturing Solutions: Driven by biologics No competitors have our comprehensive, rapid and efficient testing platform for microbial detection and identification - Only >10% of endotoxin testing volume converted to rapid testing methods - long runway for future growth Increased number of biologics in development, fueled by C&GT programs - ~3,300 C&GT programs in the biopharma R&D pipeline, with >2/3 of programs in preclinical phase Recent M&A established premier C&GT CDMO portfolio in high-growth market Charles River - JP Morgan Conference Presentation COGNATE BIOSERVICES* Vigene Biosciences Excellerce in Gene Delivery A Charles River Company 15

View entire presentation